|
|
Article: Emergent, ActivBiotics File For IPOs In Stingy Market.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
Two companies - Gaithersburg, Md.-based Emergent BioSolutions Inc., and Lexington, Mass.-based ActivBiotics Inc. - filed for their IPOs this week, hoping to raise as much as $86.25 million and $46 million, respectively. Both companies were in SEC-imposed quiet periods Tuesday. If their IPOs are completed, their stocks would be listed on the Nasdaq National Market under "EBSI" for Emergent and "ACTV" for ActivBiotics.
They join 14 other biotech firms in line to go public. According to BioWorld Industry Snapshots, in the first seven months of this year, the industry has conducted 18 IPOs, raising a total of $824.5 million for an ...
Related newspaper, magazine, and journal articles:
|
|
Article: Trading Alert for Emergent BioSolutions, Inc.
M2 Presswire;
February 23, 2007 ;
700+ words
... ... largest near-term driver for Emergent continues to be securing of ... generation anthrax vaccine. Emergent shares dropped $1.47, or ... 56 in midday trading on the New York Stock Exchange. The stock ... of $17.75 on Jan. 25. Emergent began trading on Nov. 15 ...
|
|